Recap: AbCellera Biologics Q1 Earnings

AbCellera Biologics ABCL reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

AbCellera Biologics reported in-line EPS of $-0.14 versus an estimate of $-0.14.

Revenue was down $304.39 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.12% drop in the share price the next day.

Here's a look at AbCellera Biologics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0 0.04 -0.02 0.33
EPS Actual -0.1 0.08 -0.02 0.54
Revenue Estimate 50.80M 74.95M 53.59M 194.67M
Revenue Actual 21.55M 101.38M 45.92M 316.58M

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!